Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6145117 | American Journal of Obstetrics and Gynecology | 2014 | 7 Pages |
Abstract
Deletion of 1p occurs in approximately one-quarter of CL cases. This genetic alteration is potentially associated with clinicopathologic features that are present in uterine sarcomas, which suggests a distinct clinical entity that may have malignant potential. Our findings are particularly pertinent considering the increased preference for uterine-sparing options in leiomyoma treatment, suggesting assessment of 1p deletion status in CL may influence clinical surveillance decisions.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jennelle C. PhD, Kathryn E. MS, Amy C. MD, Florin A. MD, Elizabeth A. MD,